TM4SF19 and vitiligo: After adjusting for age and sex, T cells from patients with vitiligo remained significantly elevated in the expression levels of Lnc-ARRDC3-1 (1.61-fold; p=0.011), PLCG1 (1.37-fold; p < 0.001), A_33_P3229958 (1.46-fold; p=0.045), TERM1 (2.04-fold; p < 0.001), RAB13 (1.36-fold; p=0.009), and LOC100506314 (1.85-fold; p=0.011), and decreased in the expression levels of TM4SF19 (0.38-fold; p < 0.001), IFI27 (0.43-fold; p=0.001), and IL17RB (0.70-fold; p=0.027) compared to those in controls.